IP Library Granted Patent US 9,744,139
Granted Patent B2
US 9,744,139 · App. 13/262,841 · Granted Aug 29, 2017

Modular ingestible drug delivery capsule

Inventors: Johan Frederik Dijksman (Eindhoven, NL); Anke Pierik (Eindhoven, NL); Frits Tobi De Jongh (Eindhoven, NL); Jeff Shimizu (Cortlandt Manor, NY); Hans Zou (Windsor, NJ); Lucian Remus Albu (Forest Hills, NY); Olaf Weiner (Eindhoven, NL)
Assignee: Stoco 10 GmbH
A61K9/4808A61K9/0009A61K9/0097A61M31/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,744,139
App. No.
13/262,841
Granted
Aug 29, 2017
Kind
B2
Abstract

An ingestible capsule ( 10 ) is provided for delivery of a drug, the capsule ( 10 ) comprises a first module ( 11 ) and a second module ( 12 ). The first module ( 11 ) has at least one drug compartment ( 13 ) for comprising an amount of the drug. The drug compartment ( 13 ) is sealed by a foil ( 14 ) with an embedded conducting heating wire ( 15 ). The second ( 12 ) module comprises electronics ( 18 ) for providing an electrical pulse to the heating wire ( 15 ) in order to open the drug compartment ( 13 ) by melting the foil ( 14 ). The first module ( 11 ) and second module ( 12 ) comprise interoperable connection means ( 19 ) for securing the first module ( 11 ) to the second module ( 12 ) such that the heating wire ( 15 ) is electronically coupled to the electronics ( 18 ).

Claims (63)

1. An ingestible capsule for delivery of a drug, the capsule comprising:

a first module comprising:

a sidewall defining a drug compartment for containing an amount of the drug,

a window formed as an opening through the sidewall of the drug compartment;

a foil fixed to the sidewall of the drug compartment and covering the window,

a conducting heating wire contacting the foil,

an indicator conducting trace across the conducting heating wire, and

at least one first conductive element electrically connected to the conducting heating wire, and

a second module comprising:

a power source;

electronics in communication with the power source for controlling an electrical pulse, and

at least one second conductive element electrically connected to the power source,

wherein securing the first module to the second module electrically connects the first conductive element and the second conductive element to electrically couple the heating wire to the electronics, and

wherein the conducting heating wire is configured to break the foil with an applied current and breaking the foil causes the indicator conducting trace to open at the portion extending across the conducting heating wire, the opening of the indicator conducting trace indicating that the conducting heating wire has broken the foil.

2. An ingestible capsule as claimed in claim 1 , further comprising a sliding contact for securing the first module to the second module.

3. An ingestible capsule as claimed in claim 1 , further comprising a set of pins and sockets for securing the first module to the second module.

4. An ingestible capsule as claimed in claim 1 , further comprising a screw thread for securing the first module to the second module.

5. An ingestible capsule as claimed in claim 1 , wherein the electronics comprise at least one capacitor for increasing an intensity of the electrical pulse.

6. An ingestible capsule as claimed in claim 1 , wherein an inner wall of the drug compartment is provided with an anti-sticking layer.

7. An ingestible capsule as claimed in claim 1 , wherein the foil comprises a plastic.

8. An ingestible capsule as claimed in claim 7 , wherein the plastic comprises low density polyethylene (LDPE).

9. An ingestible capsule as claimed in claim 1 , wherein the foil is covered with Polychlorotrifluorethylene (PFTE).

10. An ingestible capsule as claimed in claim 1 , wherein the heating wire is a printed electrically conducting trace.

11. An ingestible capsule as claimed in claim 1 , wherein the indicator trace is electrically connected to the electronics.

12. An ingestible capsule as claimed in claim 1 , wherein the first module comprises more than one drug compartment for comprising the amount of the drug, each drug compartment being sealed by a separate foil with an embedded conducting heating wire, the first conductive element being arranged for separately coupling each one of the heating wires to the electronics.

13. An ingestible capsule for delivery of a drug, the capsule comprising:

a first module comprising:

a first sidewall comprising an outer surface of the first module and defining a drug compartment,

a window formed as an opening through the first sidewall;

a polymer foil covering the window to prevent drug in the drug compartment from exiting through the window,

a metallic conducting heating wire embedded in the polymer foil,

a first connector at a termination of the first sidewall, and

a first conductive element disposed on the first connector and electrically connected to the conducting heating wire, and

a second module comprising:

a second sidewall comprising an outer surface of the second module and defining a volume,

a power source disposed in the volume;

electronics in the volume and in communication with the power source,

a second connector at a termination of the second sidewall and configured to cooperate with the first connector to secure the second module to the first module, and

a second conductive element disposed on the second connector and electrically connected to the power source,

wherein cooperation of the first connector with the second connector to secure the second module to the first module electrically connects the first conductive element and the second conductive element to electrically couple the heating wire to the electronics.

14. The ingestible capsule of claim 13 , wherein the first connector is a first sliding contact upon which the first conductive element is disposed and the second connector is a second sliding contact upon which the second conductive element is disposed.

15. The ingestible capsule of claim 13 , wherein the first connector is a first thread, the second connector is a second thread, the first conductive element is disposed in the first thread, and the second conductive element is disposed in the second thread.

16. The ingestible capsule of claim 13 , further comprising an indicator trace positioned orthogonal to the heating wire.

17. The ingestible capsule of claim 13 , the first module further comprising a lid proximate the termination of the sidewall to seal the drug compartment.

18. An ingestible capsule for delivery of a drug, the capsule comprising:

a first module comprising:

a sidewall defining an internal volume

a separation wall separating the internal volume into a first drug compartment and a second drug compartment,

a first window formed as an opening through the sidewall proximate the first drug compartment, placing the first drug compartment in fluid communication with an exterior of the capsule,

a second window formed as an opening through the sidewall proximate the second drug compartment, placing the second drug compartment in fluid communication with the exterior of the capsule;

a first foil covering the first window to seal the first drug compartment,

first conducting heating wire contacting the first foil,

a second foil covering the second window to seal the second drug compartment,

a second conducting heating wire contacting the second foil,

at least one first conductive element electrically connected to at least one of the first conducting heating wire or the second conducting heating wire,

an indicator conducting trace across the first conducting heating wire; and

a second module comprising:

a power source;

electronics in communication with the power source for controlling an electrical pulse, and

at least one second conductive element electrically connected to the power source,

wherein securing the first module to the second module electrically connects the first conductive element and the second conductive element to electrically couple the first and second conducting heating wires to the electronics, and

wherein the first conducting heating wire is configured to break the first foil with an applied current and breaking the first foil causes the indicator conducting trace to open at the portion extending across the first conducting heating wire, the opening of the indicator conducting trace indicating that the first conducting heating wire has broken the first foil.

19. The ingestible capsule of claim 18 , the first module further comprising a lid disposed in an axial opening proximate a termination of the sidewall to seal the drug compartments.

Assignments (9)
SECURITY INTEREST Recorded Aug 15, 2025
From: BT BIDCO, INC.
To: GLAS USA LLC
Reel/Frame 072473/0861 →
LIEN Recorded Mar 31, 2025
From: BIORA THERAPEUTICS, INC.
To: BT BIDCO LLC
Reel/Frame 070690/0864 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2025
From: BIORA THERAPEUTICS, INC.
To: BT BIDCO, INC.
Reel/Frame 070688/0297 →
SECURITY INTEREST Recorded Dec 21, 2023
From: BIORA THERAPEUTICS, INC.
To: GLAS TRUST COMPANY LLC, AS COLLATERAL AGENT
Reel/Frame 066089/0235 →
CHANGE OF NAME Recorded Sep 19, 2023
From: PROGENITY, INC.
To: BIORA THERAPEUTICS, INC.
Reel/Frame 064961/0451 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2018
From: STOCO 10 GMBH
To: PROGENITY, INC.
Reel/Frame 045831/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2017
From: MEDIMETRICS PERSONALIZED DRUG DELIVERY B.V.
To: STOCO 10 GMBH
Reel/Frame 043463/0820 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2012
From: KONINKLIJKE PHILIPS ELECTRONICS N.V.
To: MEDIMETRICS PERSONALIZED DRUG DELIVERY B.V.
Reel/Frame 027756/0865 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2012
From: DIJKSMAN, JOHAN FREDERIK; PIERIK, ANKE; DE JONGH, FRITS TOBI; SHIMIZU, JEFF; ZOU, HANS; ALBU, LUCIAN REMUS; WEINER, OLAF
To: KONINKLIJKE PHILIPS ELECTRONICS N V
Reel/Frame 027537/0402 →
Continuity (2)
Provisional Application 61167240 · Apr 7, 2009
Related Publication 20120116358A1 · May 10, 2012